Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02094261 |
|---|---|
| Brief Title: | Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours (AURA2) |
| First Submitted : | March 17, 2014 |
| First Submitted that Met QC Criteria : | March 20, 2014 |
| First Posted : | March 21, 2014 (Estimate) |
| Results First Submitted : | April 28, 2016 |
| Results First Submitted that Met QC Criteria : | April 28, 2016 |
| Results First Posted : | June 7, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 5, 2021 |
| Last Update Posted : | February 23, 2021 |